FDA Regulatory-Rulemaking from Real-World Data from Registries

Food and Drug Administration draft guidance outlining recommendations for using real-world data from registries to support regulatory decision-making. Pharmaceutical manufacturers and other life-sciences industry stakeholders should review guidance & submit comments by February 28, 2022

Related Keywords

,Product Development To Support Labeling ,Drug Administration ,Real World Data ,Assessing Registries ,Support Regulatory Decision Making ,Biological Products Guidance ,Draft Guidance ,Century Cures Act ,Cures Act ,Federal Food ,Cosmetic Act ,Regulatory Decision ,Patient Reported Outcome Measures ,Medical Product Development ,Support Labeling ,Linking Registries ,Legal ,Government ,Regulation ,Fda ,Urating Data In Registries ,Pharmaceutical Manufacturers ,Ive Sciences Industry ,